Raleigh pharma raises $5M as phase 3 study begins
March 16, 2023 at 07:44 AM EDT
A Raleigh pharmaceutical company is raising money as it moves its lead drug into a late-stage study.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |